Related Experiment Video
Updated: May 16, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Is there a relationship between serum heart- type fatty acid binding protein level and clinical severity in patients
Metehan Yilman1, Cengiz Cokluk, Ahmet Baydin
1Ondokuzmayis University, Faculty of Medicine, Department of Emergency, Samsun, Turkey.
Insights
Serum heart-type fatty acid binding protein (H-FABP) levels are elevated in patients with subarachnoid hemorrhage (SAH). Higher H-FABP levels correlate with increased SAH severity, but not ECG changes.
Area of Science:
- Cardiology
- Neurology
- Biochemistry
Background:
- Subarachnoid hemorrhage (SAH) can lead to cardiac complications.
- Heart-type fatty acid binding protein (H-FABP) is a potential biomarker for cardiac injury.
Purpose of the Study:
- To assess serum H-FABP levels in SAH patients.
- To investigate the relationship between H-FABP and cardiac effects in SAH.
- To explore correlations with SAH severity grading scales.
Main Methods:
- Included 46 acute SAH patients and 20 healthy controls.
- Performed 12-lead ECG on admission for all patients.
- Measured serum H-FABP levels upon patient admission.
Main Results:
- SAH patients exhibited significantly higher serum H-FABP levels than controls (p < 0.05).
- No significant correlation was found between H-FABP levels and ECG changes.
- Moderate positive correlation between H-FABP and Hunt and Hess grade (r=0.43, p < 0.05).
- Weak positive correlation between H-FABP and Fisher radiological grade (r=0.38, p < 0.05).
Conclusions:
- Serum H-FABP levels are elevated in patients with SAH.
- Increased H-FABP levels are associated with higher SAH severity based on Hunt and Hess and Fisher classifications.
Aim:
The aim of this study was to determine the serum heart-type fatty acid binding protein (H-FABP) levels and cardiac effects in patients presenting with subarachnoid hemorrhage (SAH) and to investigate whether any correlation exists between the cardiac effects and H-FABP.
Material And Methods:
Forty-six patients diagnosed as acute SAH in the emergency department were included in this study. Twenty healthy adults were included in the study to serve as controls. Twelve-lead ECG was performed on all patients on admission. H-FABP levels of patients were determined in serum samples taken on admission.
Results:
Serum H-FABP levels of patients were found to be significantly higher than those of controls (p < 0.05). There was no significant correlation between serum H-FABP levels and ECG changes. There was a moderate positive correlation between H-FABP serum levels and the grade according to the Hunt and Hess classification (r=0.43, p < 0.05). There was a weak positive correlation between H-FABP serum levels and the grade according to the Fisher radiological classification (r=0.38, p < 0.05).
Conclusion:
Serum H-FABP levels are increased in patients with SAH. Grades according to the Hunt and Hess and Fisher grading scales were shown to increase in conjunction with an increase in H-FABP levels.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
